Investor Relations SciBase

KALLELSE till årsstämma i SciBase Holding AB publ - Redeye

”uniträtter”) och fem (5) uniträtter berättigar till teckning av en (1) unit. Varje unit består av en (1) aktie och en (1) teckningsoption. 1 day ago Founded in 1998, SciBase AB is a Swedish medical technology company, headquartered in Stockholm, that has developed a unique point of care device for the accurate detection of malignant melanoma. The Scibase method is based on a technology called Electrical Impedance Spectroscopy (EIS), which uses the varying electrical properties of human 2 days ago 2 days ago 1 day ago 1 day ago Find the latest Scibase Holding AB (SCIB.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. View SciBase (www.scibase.com) location in Stockholm, Sweden , revenue, industry and description. Find related and similar companies as well as employees by title and much more.

Våra analytiker har över 50 års samlad börserfarenhet. Senaste och historiska P/E, direktavkastning och DCF värderingar för Scibase. 2020 1m 3m 6m YTD 1y 3y 5y 10y All Aktiekurs Scibase - OMX Stockholm. SciBase AB is a Swedish medical technology company, headquartered in Stockholm that has developed and sells a unique point-of-care device for evaluation of skin disorders such as skin cancer and atopic dermatitis. Its first product, Nevisense, helps doctors to detect malignant melanoma, the most dangerous type of skin cancer. The SciBase share. Coming events.

Michael Colerus - CFO - Scibase AB LinkedIn

no. 556773-4768 (the "Company"), are hereby given notice to attend the annual general meeting at 2:00 p.m. on Tuesday 18 May 2021.

Securities with Special Margin Requirements Interactive

Stockholm, 31 mars 2017 - Redeye tar idag upp bevakningen av diagnostikbolaget SciBase Holding. Bolaget har utvecklat Nevisense som Affärsvärlden är en tjänst för dig med ett brinnande intresse för börs- och aktiehandel. Våra analytiker har över 50 års samlad börserfarenhet. Senaste och historiska P/E, direktavkastning och DCF värderingar för Scibase.

”uniträtter”) och fem (5) uniträtter berättigar till teckning av en (1) unit. Varje unit består av en (1) aktie och en (1) teckningsoption. 1 dag sedan · The shareholders in SciBase Holding AB (publ), reg. no.
Amd uudet näytönohjaimet

A new Study that validates an expansion of Nevisense indication for Non-melanoma Skin Cancer Gasporox, \n, GC Rieber Shipping, \n, Generic Sweden, \n, Genesis IT, \n, Genova Property Group Pref, \n, Genovis, \n, Getinge B, \n, GHP Specialty Care AB Gasporox, \n, GC Rieber Shipping, \n, Generic Sweden, \n, Genesis IT, \n, Genova Property Group Pref, \n, Genovis, \n, Getinge B, \n, GHP Specialty Care AB Köp Scibase Holding AB (SCIB) aktier - Nordnet; Ibt aktie. Scibase SciBase Holding AB is a Sweden-based company engaged in the medical SciBase Holding AB (publ) - Företagsinformation - Allabolag — SciBase Holding AB is a Sweden-based company engaged in the Ger dig företagsinformation om SciBase Holding AB (publ), 556773-4768. 2021-01-: SciBase Holding AB is a Sweden-based company engaged in the Bolaget, som har sitt huvudkontor i Stockholm, är börsnoterat på Nasdaq First North sedan 2 juni 2015. Vd sedan år 2014 är Simon Grant, som Byggvaruhuset K-Rauta erbjuder gedigna produkter och tjänster inom badrum, trädgård, verktyg, bygg och inredning.

Last Updated. 2021/04/05 18:03 UTC. Data Sources. Company Financials + 1 Analyst. Executive Summary. SciBase Holding AB (publ), a medical technology company, develops and sells instruments for the detection of skin cancer and other skin conditions.in Europe and SciBase Holding AB is a Sweden-based company engaged in the medical equipment industry. The Company specializes in the manufacture of point of care device, called Nevisense, which is aimed to detect of malignant melanoma.
Flatfrog photography

SCIB | Complete SciBase Holding AB stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Köp aktier i Scibase Holding - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Sweden AB. Med ”SEK” avses SciBase Holding AB (publ) är ett svenskt publikt aktiebolag som registrerades den 18 december 2008 och vars verksamhet bedrivs enligt svensk rätt.
Falsk brandlarm pris

Electrical impedance spectroscopy for the characterization of

The Company designs and develops screening methods for improving the accuracy, speed, and early detection of STOCKHOLM, SWEDEN, - April 12, 2021 - SciBase Holding AB ("SciBase") [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today the publication of a new clinical study supporting SciBase's strategy to develop multiple clinical applications for the Nevisense and Nevisense Go platforms. SciBase AB is a global medical technology company based in Stockholm, Sweden that develops unique point-of-care devices for the evaluation of skin disorders such as skin cancer and atopic SciBase Holding AB is a Sweden-based company engaged in the medical equipment industry. The Company specializes in the manufacture of point of care device, called Nevisense, which is aimed to SciBase Holding AB Its product includes Nevisense, which is a diagnostic support tool for non-visual detection of malignant melanoma. The company was founded by Stig Gösta Ollmar in 1998 and is Stock analysis for Scibase Holding AB (SCIB:FN Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile.